Cv for a. westfall

CURRICULUM VITAE

NAME: Andrew O. Westfall, M.S.
PREPARED: December 15, 2010

HOME ADDRESS / PHONE NUMBER:
BUSINESS ADDRESS / PHONE NUMBER:

BIRTHDATE: July xx, 1969
BIRTHPLACE: Charleston, West Virginia

SOCIAL SECURITY NUMBER:
MARITAL STATUS:

EDUCATION:
University of Florida
Gainesville, Florida University of Florida

MEMBERSHIPS IN PROFESSIONAL ORGANIZATIONS:
American Statistical Association
ASA Alabama Chapter
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 2

POSITIONS HELD:
October 19, 2010 – Current
Database Analyst III, Center for AIDS Research, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham Alabama.
August 1, 2008 – October 18, 2010
Database Analyst III, Department of Obstetrics and Gynecology, Division of International Women’s Health, University of Alabama at Birmingham, CIDRZ (Centre for Infectious Disease Research in Zambia), Lusaka Zambia. Lead Statistician, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham Alabama.
February 1, 2002 – February 28, 2003
Statistician, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham Alabama. Statistician, Biostatistics Unit, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham Alabama.
February 1, 1996 – November 9, 1997
Statistician/Programmer, CARDIA Coordinating Center, University of Alabama at Birmingham, Birmingham Alabama. Statistician/Programmer, Civitan International Research Center, University of Alabama at Birmingham, Birmingham Alabama. Graduate Teaching Assistant, University of Florida, Gainesville Florida. CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 3

TEACHING EXPERIENCE:

Fall 2005, Introduction to Data Management and Reporting Using the SAS System (Instructor)
Fall 2004, Introduction to Data Management and Reporting Using the SAS System (Instructor)
Fall 2003, Introduction to Data Management and Reporting Using the SAS System (Instructor)

Fall 2002, Introduction to Data Management and Reporting Using the SAS System (Co-Instructor)
Spring 1994, Introduction to Statistics (Teaching Assistant)
Fall 1993, Introduction to Statistics (Teaching Assistant)
Summer 1993, Statistical Methods in Social Research (Teaching Assistant)
Spring 1993, Introduction to Statistics (Teaching Assistant)
Fall 1992, Introduction to Statistics (Teaching Assistant)
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 4
BIBLIOGRAPHY

MANUSCRIPTS PUBLISHED:

1. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M. Bacteremia
Associated with Tunneled Dialysis Catheters: Comparison of Two Treatment Strategies.
Kidney Int 2000 May;57(5):2151-5.
2. Childs HA III, Cole T, Falkenberg E, Smith JT, Alonso JE, Stannard JP, Spencer SA, Fiveash J, Raben D, Bonner JA, Westfall AO, Kim RY. A Prospective Evaluation of the Timing of
Postoperative Radiotherapy for Preventing Heterotopic Ossification Following Traumatic
Acetabular Fractures. Int J Radiat Oncol Biol Phys 2000 Jul 15;47(5):1347-52.
3. Call SA, Klapow J, Stewart KE, Westfall AO, Mallinger AP, DeMasi RA, Centor R, Saag MS. Health-related Quality of Life and Virologic Outcomes in an HIV Clinic. Qual Life Res
2000;9(9):977-85.
4. Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA. Phenotypic Drug Susceptibility Testing Predicts Long-Term Virologic
Suppression Better than Treatment History in Patients with Human Immunodeficiency
Virus Infection. J Infect Dis 2001 Feb 1;183(3):401-8.
5. Lilly RZ, Carlton D, Barker J, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M. Predictors of Arteriovenous Graft Patency After Radiologic Intervention in Hemodialysis
Patients. Am J Kidney Dis 2001 May;37(5):945-53.
6. Bild DE, Folsom AR, Lowe LP, Sidney S, Kiefe C, Westfall AO, Zheng ZJ, Rumberger J. Prevalence and Correlates of Coronary Calcification in Black and White Young Adults:
The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler
Thromb Vasc Biol 2001 May;21(5):852-7.
7. Chen RY, Westfall AO, Raper JL, Cloud GA, Chatham AK, Acosta EP, Pham SV, Tolson JM, Heudebert GR, Saag MS. Immunologic and Virologic Consequences of Temporary
Antiretroviral Treatment Interruption in Clinical Practice. AIDS Res Hum Retroviruses
2002 Sep 1;18(13):909-16.
8. Ferguson TF, Stewart KE, Funkhouser E, Tolson J, Westfall AO, Saag MS. Patient-Perceived
Barriers to Antiretroviral Adherence: Associations with Race. AIDS Care 2002
Oct;14(5):607-17.
9. Vaughan WP, Carey D, Perry S, Westfall AO, Salzman DE. A Limited Sampling Strategy for
Pharmacokinetic Directed Therapy with Intravenous Busulfan. Biol Blood Marrow
Transplant. 2002;8: 619-624.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 5
10. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of Life Lost Due to
Obesity. JAMA 2003;289:187-193.
11. Jordan WD, Alcocer F, Wirthlin DJ, Westfall AO, Whitley D. Abdominal aortic aneurysms in
"High-Risk" surgical patients: comparison of open and endovascular repair. Ann Surg.
2003 May;237(5):623-30.
12. Chen RY, Westfall AO, Mugavero MJ, Cloud GA, Raper JL, Chatham AG, Acosta EP, Taylor KH, Carter J, Saag MS. Duration of highly active antiretroviral therapy regimens. Clin
Infect Dis. 2003 Sep 1;37(5):714-22.
13. Canon CL, Smith JK, Morgan DE, Jones BC, Fell SC, Kenney PJ, Ferrante D, Lockhart ME, Westfall AO, Koehler RE. Double reading of barium enemas: is it necessary? AJR Am J
Roentgenol. 2003 Dec;181(6):1607-10.
14. Dorak MT, Tang J, Penman-Aguilar A, Westfall AO, Zulu I, Lobashevsky ES, Kancheya NG, Schaen MM, Allen SA, Kaslow RA. Transmission of HIV-1 and HLA-B allele-sharing
within serodiscordant heterosexual Zambian couples. Lancet. 2004 Jun 26;363(9427):2137-
9.
15. Pamboukian SV, Costanzo MR, Dunlap S, Rayburn B, Westfall AO, You ZY, Hung E, McLeod M, Heroux A. Relationship between bridging with ventricular assist device on rejection
after heart transplantation. J Heart Lung Transplant. 2005 Mar;24(3):310-5.
16. LeCroy CJ, Patterson MA, Taylor SM, Westfall AO, Jordan WD. Effect of Warfarin
Anticoagulation on Below-Knee Polytetrafluoroethylene Graft Patency. Ann Vasc Surg.
2005 Mar;19(2):192-8.
17. Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A, Spettell CM, Weissman NW, Wilke S, Saag KG. Longitudinal patterns in the prevention of osteoporosis in
glucocorticoid-treated patients. Arthritis Rheum. 2005 Aug;52(8):2485-94.
18. Mikuls TR, Saag KG, Curtis J, Bridges SL Jr, Alarcon GS, Westfall AO, Lim SS, Smith EA, Jonas BL, Moreland LW. Prevalence of osteoporosis and osteopenia among African
Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J
Natl Med Assn. 2005 Aug;97(8):1155-60.
19. Bedimo R, Chen RY, Westfall AO, Raper JL, Allison JJ, Saag MS. Sustained HIV Viral
Suppression following Treatment Interruption: An Observational Study. AIDS Res Hum
Retroviruses. 2006 Jan;22(1):40-4.
20. Curtis JR, Westfall AO, Allison J, Freeman A, Kovac SH, Saag KG. Agreement and validity
of pharmacy data versus self-report for use of osteoporosis medications among chronic
glucocorticoid users. Pharmacoepidemiol Drug Saf. 2006 Oct;15(10):710-8.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 6
21. Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, Stone BK, Carter J, Call S, Pisu M, Allison J, Saag MS. Distribution of Health Care Expenditures for HIV-
Infected Patients. Clin Infect Dis. 2006 Apr 1;42(7):1003-10.
22. Curtis JR, Westfall AO, Allison JJ, Freeman A, Saag KG. Channeling and adherence with
alendronate and risedronate among chronic glucocorticoid users. Osteoporos Int.
2006;17(8):1268-74.
23. Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG. Population-based assessment of adverse events associated with long-term
glucocorticoid use. Arthritis Rheum. 2006 Jun 15;55(3):420-6.
24. Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM, Ruden D, Pietrobelli A, Barger JL, Fontaine KR, Wang C, Aronne LJ, Wright SM, Baskin M, Dhurandhar
NV, Lijoi MC, Grilo CM, Deluca M, Westfall AO, Allison DB. Putative contributors to the
secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond). 2006
Nov;30(11):1585-94.
25. Fabres J, Wehrli G, Marques MB, Phillips V, Dimmitt RA, Westfall AO, Schelonka RL. Estimating blood needs for very-low-birth-weight infants. Transfusion. 2006
Nov;46(11):1915-20.
26. Bagchi S, Kempf MC, Westfall AO, Maherya A, Willig J, Saag MS. Can routine clinical
markers be used longitudinally to monitor antiretroviral therapy success in resource-
limited settings? Clin Infect Dis. 2007 Jan 1;44(1):135-8.
27. Chen RY, Westfall AO, Hardin JM, Miller-Hardwick C, Stringer JS, Raper JL, Vermund SH, Gotuzzo E, Allison J, Saag MS. Complete Blood Cell Count as a Surrogate CD4 Cell
Marker for HIV Monitoring in Resource-Limited Settings. J Acquir Immune Defic Syndr.
2007 Apr 15;44(5):525-30.
28. Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG. Challenges in improving the quality of
osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch
Intern Med. 2007 Mar 26;167(6):591-6.
29. Shikany JM, Barash J, Redden DT, Westfall AO, Heimburger DC, Henson CS, Allison DB. Divergence in popular diets relative to diets consumed by Americans, and implications for
diet selection. MedGenMed. 2007 Jul 9;9(3):8.
30. Willig JH, Westfall AO, Allison J, Wagoner NV, Chang PW, Raper J, Saag MS, Mugavero MJ. Nucleoside Reverse-Transcriptase Inhibitor Dosing Errors in an Outpatient HIV Clinic in
the Electronic Medical Record Era. Clin Infect Dis. 2007 Sep 1;45(5):658-61.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 7
31. Mark KE, Meinzen-Derr J, Stephenson R, Haworth A, Ahmed Y, Duncan D, Westfall A, Allen S. Contraception among HIV Concordant and Discordant Couples in Zambia: A
Randomized Controlled Trial. J Womens Health (Larchmt). 2007 Oct;16(8):1200-10.
32. Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D, van Everdingen M, Alarcon GS, Conn DL, Jonas B, Callahan LF, Smith EA, Gilkeson G, Howard G, Moreland
LW, Bridges SL Jr. Cigarette smoking, disease severity, and autoantibody expression in
African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis. 2008
Nov;67(11):1529-34.
33. Hughes LB, Morrison D, Kelley JM, Padilla MA, Vaughan LK, Westfall AO, Dwivedi H, Mikuls TR, Holers VM, Parrish LA, Alarcón GS, Conn DL, Jonas BL, Callahan LF, Smith EA,
Gilkeson GS, Howard G, Moreland LW, Patterson N, Reich D, Bridges SL Jr. The HLA-DRB1
shared epitope is associated with susceptibility to rheumatoid arthritis in African
Americans through European genetic admixture. Arthritis Rheum. 2008 Jan 31;58(2):349-
358.
34. Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, Kaslow RA, Kempf MC. Clinical
Outcome of HIV-Infected Antiretroviral-Naive Patients With Discordant Immunologic and
Virologic Responses to Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr.
2008 Apr 15;47(5):553-558.
35. Curtis JR, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E. The Benefit of Adherence
with Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of
101,038 New Bisphosphonate Users. J Bone Miner Res. 2008 Sep;23(9):1435-41.
36. Willig JH, Jackson DA, Westfall AO, Allison J, Chang PW, Raper J, Saag MS, Mugavero MJ. Clinical Inertia in the Management of Low-Density Lipoprotein Abnormalities in an HIV
Clinic. Clin Infect Dis. 2008 Apr 15;46(8):1315-8.
37. Curtis JR, Westfall AO, Cheng H, Delzell E, Saag KG. Risk of hip fracture after
bisphosphonate discontinuation: implications for a drug holiday. Osteoporos Int. 2008
Nov;19(11):1613-20.
38. Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB. Industry funding and
the reporting quality of large long-term weight loss trials. Int J Obes (Lond). 2008
Oct;32(10):1531-6.
39. Willig JH, Abroms S, Westfall AO, Routman J, Adusumilli S, Varshney M, Allison J, Chatham A, Raper JL, Kaslow RA, Saag MS, Mugavero MJ. Increased regimen durability in the era of
once-daily fixed-dose combination antiretroviral therapy. AIDS. 2008 Oct 1;22(15):1951-
1960.
40. Curtis JR, Westfall AO, Cheng H, Saag KG, Delzell E. RisedronatE and ALendronate
Intervention over Three Years (REALITY): minimal differences in fracture risk reduction.
Osteoporos Int. 2009 Jun;20(6):973-8.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 8
41. Robison LS, Westfall AO, Mugavero MJ, Kempf MC, Cole SR, Allison JJ, Willig JH, Raper JL, Wilcox CM, Saag MS. Short-term Discontinuation of HAART Regimens More Common in
Vulnerable Patient Populations. AIDS Res Hum Retroviruses. 2008;24:1347-55.
42. Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, Abroms S, Raper JL, Saag MS, Allison JJ. Missed Visits and Mortality among Patients Establishing Initial
Outpatient HIV Treatment. Clin Infect Dis. 2009 Jan 15;48(2):248-56.
43. Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E. Improving the
Prediction of Medication Compliance: The Example of Bisphosphonates for Osteoporosis.
Med Care. 2009 Mar;47(3):334-41.
44. Kelley JM, Hughes LB, Faggard JD, Danila MI, Crawford MH, Edberg Y, Padilla MA, Tiwari HK, Westfall AO, Alarcón GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD,
Allison DB, Kimberly RP, Moreland LW, Edberg JC, Bridges SL. An African Ancestry-
Specific Allele of CTLA4 Confers Protection against Rheumatoid Arthritis in African
Americans. PLoS Genet. 2009 Mar;5(3):e1000424.
45. Tucker JA, Roth DL, Vignolo MJ, Westfall AO. A behavioral economic reward index
predicts drinking resolutions: moderation revisited and compared with other outcomes. J
Consult Clin Psychol. 2009 Apr;77(2):219-28.
46. Curtis JR, Arora T, Xi J, Silver A, Allison JJ, Chen L, Saag KG, Schenck A, Westfall AO, Colón-Emeric C. Do physicians within the same practice setting manage osteoporosis
patients similarly? Implications for implementation research. Osteoporos Int. 2009
Nov;20(11):1921-7.
47. Kempf MC, Pisu M, Dumcheva A, Westfall AO, Kilby JM, Saag MS. Gender Differences in
Discontinuation of Antiretroviral Treatment Regimens. J Acquir Immune Defic Syndr. 2009
Nov 1;52(3):336-41.
48. Willig JH, Echevarria J, Westfall AO, Iglesias D, Henostroza G, Seas C, Mugavero MJ, Allison J, Paz J 3rd, Hernandez F, Tomatis C, Saag MS, Gotuzzo E. Durability of Initial Antiretroviral
Therapy in a Resource Constrained Setting and the Potential Need for Zidovudine Weight-
Based Dosing. J Acquir Immune Defic Syndr. 2010 Feb 1;53(2):215-21.
49. McKinnell JA, Willig JH, Westfall AO, Nevin C, Allison JJ, Raper JL, Mugavero MJ, Saag MS. Antiretroviral Prescribing Patterns in Treatment-Naïve Patients in the United States. AIDS
Patient Care STDS. 2010 Feb;24(2):79-85.
50. Routman JS, Willig JH, Westfall AO, Abroms SR, Varshney M, Adusumilli S, Allison JJ, Savage KG, Saag MS, Mugavero MJ. Comparative Efficacy versus Effectiveness of Initial
Antiretroviral Therapy in Clinical Trials versus Routine Care. Clin Infect Dis. 2010 Feb
15;50(4):574-84.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 9
51. Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M. Hepatitis C virus
coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med.
2010 Aug;11(7):462-8.
52. Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, Limbada M, Mulenga LB, Vermund SH, Stringer JS. An Empirical Approach to Defining Loss to Follow-up Among Patients
Enrolled in Antiretroviral Treatment Programs. Am J Epidemiol. 2010 Apr 15;171(8):924-
31.
53. Koethe JR, Westfall AO, Luhanga DK, Clark GM, Goldman JD, Mulenga PL, Cantrell RA, Chi BH, Zulu I, Saag MS, Stringer JS. A Cluster Randomized Trial of Routine HIV-1 Viral Load
Monitoring in Zambia: Study Design, Implementation, and Baseline Cohort
Characteristics. PLoS One. 2010 Mar 12;5(3):e9680.
54. Bridges SL Jr, Causey ZL, Burgos PI, Huynh BQ, Hughes LB, Danila MI, van Everdingen A, Ledbetter S, Conn DL, Tamhane A, Westfall AO, Jonas BL, Callahan LF, Smith EA, Brasington
R, Moreland LW, Alarcón GS, van der Heijde DM. Radiographic severity of rheumatoid
arthritis in African Americans: results from a multicenter observational study. Arthritis
Care Res (Hoboken). 2010 May;62(5):624-31.
55. Hughes LB, Reynolds RJ, Brown EE, Kelley JM, Thomson B, Conn DL, Jonas BL, Westfall AO, Padilla MA, Callahan LF, Smith EA, Brasington RD Jr, Edberg JC, Kimberly RP, Moreland
LW, Plenge RM, Bridges SL Jr. Most common single-nucleotide polymorphisms associated
with rheumatoid arthritis in subjects of European ancestry confer risk of rheumatoid
arthritis in African-Americans. Arthritis Rheum. 2010 Dec;62(12):3547-53. doi:
10.1002/art.27732.
56. Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, Chibwesha C, Pfaendler KS, Mkumba G, Mudenda V, Kapambwe S, Vermund SH, Hicks ML, Stringer JSA,
Chi BH. Implementation of cervical cancer prevention services for HIV-infected women in
Zambia: measuring program effectiveness. HIV Therapy. November 2010, Vol. 4, No. 6,
Pages 713-722. doi: 10.2217/hiv.10.52.


LETTERS:

1. Allison DB, Wang C, Redden DT, Westfall AO, Fontaine KR. Obesity and Years of Life
Lost—Reply. JAMA 2003;289:1777-b-1778-b.

2. Allison DB, Wang C, Redden DT, Westfall AO, Fontaine KR. Methods of Estimating Years
of Life Lost Due to Obesity—Reply. JAMA 2003;289:2491-a-2492-a.

CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 10
PRESENTATIONS:

1. Roseman JM, Hilner JE, Cornwell PE, Westfall AO, Bild DE, Schreiner PJ. Homocysteine
(HCY) Level, Its 7-Year Change, and Possible Determinants in a Biracial Sample of Young
Adults: The CARDIA Study. Paper presented at The 4th International Conference on
Preventive Cardiology, Montreal, June 1997.
2. Bild DE, Folsom A, Westfall AO, Lowe LP, Sidney S, Kiefe C, Zheng Z, Rumberger J. Coronary Calcification in Black and White Young Adults: The CARDIA Study. Paper
presented at The 4th International Conference on Preventive Cardiology, Montreal, June 1997.
3. Stewart KE, Greene PG, Call SA, Westfall AO, Chatwood A, Saag MS. Patterns of Self-
reported Adherence to ART in a Prospective Clinical Cohort. Oral Abstract Presentation,
38th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1998.
4. Saag MS, Raper JL, Chatham A, Westfall AO, Cloud GA, Call SA. Optimal Design of Salvage
Protocols: Lessons from a Clinical Cohort. Oral Abstract Presentation, Second International
Workshop on Salvage Therapy for HIV Infection, Toronto, Canada, May 1999.
5. Call SA, Westfall AO, Cloud GA, Saag MS. Predictive Value of HIV Phenotypic
Susceptibility Testing in a Clinical Cohort. Late Breaker Presentation, 39th Interscience
Conference on Antimicrobial Agents and Chemotherapy, September 1999.
6. Childs HA, Cole T, Falkenberg E, Smith JT, Alonso JE, Stannard JP, Spencer SA, Fiveash J, Raben D, Bonner JA, Westfall AO, Kim RY. A Prospective Evaluation of the Timing of Post-
Operative Radiotherapy for Heterotopic Ossification Following Traumatic Acetabular
Fractures. Oral presentation at the 41st annual ASTRO Meeting, November 1999.
7. Johnson VA, Call SA, Westfall AO, Cloud GA, Acosta EP, Tolson JM, Larder BA, Saag MS. A
Comparison of Predictive Value of Phenotypic vs. Genotypic Susceptibility Testing (both
Expert Interpretation and Virtual Phenotype) on Long-term Virologic Suppression in an
ART Experienced Cohort. Oral presentation at the 4th International Workshop on HIV
Observational Databases Meeting, Marbella, Spain, March 2000.
8. Call SA, Johnson VA, Westfall AO, Acosta EP, Cloud GA, Ross LL, Larder BA, Saag MS. Degree of Agreement Among Interpretations of Genotypic Resistance Testing Results in a
Cohort of ART-Experienced Individuals. 40th Interscience Conference on Antimicrobial
Agents and Chemotherapy, September 2000.
9. Saag MS, Chen RY, Westfall AO, Cloud GA, Raper JL, Chatham A, Call SA, Acosta EP, Heudebert G. Immunologic and Virologic Consequences of Antiretroviral Treatment
Interruption (TI) in Clinical Practice. Late Breaker 40th Interscience Conference on
Antimicrobial Agents and Chemotherapy, September 2000.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 11
10. Chen RY, Westfall AO, Cloud GA, Call SA, Johnson VA, Raper JL, Stewart K, Acosta EP, Chatham A, Taylor K, Saag MS. Immunologic and Virologic Consequences of Antiretroviral
Treatment Interruption (TI) in Clinical Practice. Presentation at Strategic Treatment
Interruption Workshop, Chicago, Illinois, October 2000.
11. Chen RY, Westfall AO, Raper JL, Chatham A, Taylor K, Acosta EP, Stewart KE, Carter J, Heudebert G, Cloud GC, Saag MS. Defining Virologic Failure: Getting into the GAPS.
Abstract presentation, 5th International Workshop on HIV Observational Databases Meeting,
Monte Carlo, Monaco, April 2001.
12. Baker CH, Newsome J, Westfall AO, Belser WB, Baum S, Shuster JL. Feasibility Study of
Multidimensional Clinical Assessment in Palliative Care. American Academy of Hospice
and Palliative Medicine.
13. Saag MS, Chen RY, Call SA, Raper JL, Westfall AO, Accortt NA, Cloud GC, Allison J. Current Controversies in Antiretroviral Therapy. Plenary Session, The XIV International
AIDS Conference, Barcelona, Spain, 2002 (July 7-12).
14. Jordan WD, Alcocer F, Wirthlin DJ, Westfall AO, Whitley D. Endovascular Repair of
Abdominal Aortic Aneurysms for “High Risk” Surgical Patients. Southern Surgical
Association, Palm Beach, FL, December 2, 2002.

15. Chen RY, Westfall AO, Hardin M, Vermund SH, Saag MS. Complete Blood Count (CBC) as
a Surrogate Marker for HIV Monitoring in Resource-Limited Settings [abstract G2-9]. 10th
Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2003 (Feb 10-14).
16. Chen RY, Westfall AO, Hardin M, Saag MS. Red Alert: Identifying Predictors of Mortality
in HIV-Infected Individuals. 7th International Workshop on HIV Observational Databases,
Fiuggi, Italy, March 2003.
17. Bedimo RJ, Westfall AO, Chen RY, Saag MS. Sustained HIV Viral Suppression Following
Treatment Interruption: An Observational Study. 41st Annual Meeting of IDSA, San Diego,
CA, 2003 (Oct 9-12).
18. Callahan LF, Jonas B, Westfall AO, Gilkeson G, Conn D, Gala P, Howard G, Bridges SL Jr., Moreland LW. Complementary and Alternative Medicine Use in African Americans with
Early Rheumatoid Arthritis (RA). ACR/ARHP Annual Scientific Meeting, Orlando, FL, 2003
(Oct 23-28).
19. Callahan LF, Jonas B, Westfall AO, Gilkeson G, Conn D, Oliver E, Howard G, Bridges SL Jr., Moreland LW. Health-Related Quality of Life in African Americans with Early
Rheumatoid Arthritis (RA). ACR/ARHP Annual Scientific Meeting, Orlando, FL, 2003 (Oct
23-28).
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 12
20. Fabres J, Wehrli G, Marques M, Phillips V, Dimmitt R, Westfall AO, Shelonka R. Analysis of
Risk Factors for Red Blood Cell Transfusions in VLBW Infants. 28th Southeastern
Conference on Perinatal Research, Hawk's Cay Resort, Duck Key, FL, 2004 (Feb).
21. LeCroy C, Taylor S, Patterson M, Westfall AO, Jordan WD. The Effect of Warfarin
Anticoagulation on below-knee PTFE Graft Patency. Peripheral Vascular Surgery Society,
Anaheim, CA, 2004 (Jun 4-5).
22. Curtis JR, Westfall AO, Allison JJ, Freeman A, Kovac SH, Spettell CM, Saag KG. Agreement
and Validation of Self-report and Pharmacy data for Use of Anti-Osteoporosis
Medications. International Society of Pharmacoepidemiology, Nashville, TN, August 2005.
23. Kempf MC, Pisu MA, Maherya A, Westfall AO, Cloud G, Saag MS. Racial Differences in
Discontinuation of Efavirenz Treatment. 23rd International Conference on
Pharmacoepidemiology & Therapeutic Risk Management, Québec City, Canada, August 19-22,
2007.
24. Willig J, Kumar M, Gupta S, Westfall A, Saag M, Raper J, Mugavero M. Provider
Documentation Accuracy Rates: A Continuous Quality Improvement Initiative at the 1917
Clinic. TEPR, Dallas, TX, 2007 (May 19-23).
25. Bedimo RJ, Westfall AO, Mugavero MJ, Drechsler H, Khanna N, Saag MS. HCV Co-Infection
and Risk of Acute Myocardial and Cerebrovascular Disease Among HIV-Infected Patients
in the Pre-HAART and HAART Eras. The XVII International AIDS Conference, Mexico
City, Mexico, 2008 (August 3-8).
26. Bedimo RJ, Westfall AO, Tebas P, Drechsler H. Abacavir Use and Risk of Acute Myocardial
Infarction and Cerebrovascular Disease in the HAART era. The 5th IAS Conference on HIV
Pathogenesis, Treatment and Prevention, Cape Town 19-22 July 2009. Abstract MOAB202.

POSTERS:

1. Call SA, Westfall AO, Pham S, Chatwood A, Cloud G, Raper J, Saag MS. Patterns of
Antiretroviral Therapy Use from 1988-1998 in a Cohort of HIV-Infected Individuals. The
12th World AIDS Conference, Geneva, July 1998.
2. Saag MS, Cloud G, Raper J, Tolson J, McKinnon S, Chatham A, Call SA, Westfall AO. Predictors of Failure of Antiretroviral Therapy in a Prospective Clinic Cohort. The 12th
World AIDS Conference, Geneva, July 1998.
3. Stewart KE, Call SA, Cloud GA, Westfall AO, McKinnon SL, Chatham AG, Saag MS. Prospective Prediction of ARV Adherence: The Role of Patient-Perceived Barriers. 39th
Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1999.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 13


4. Call SA, Raper JL, Westfall AO, Chatham A, McKinnon S, Saag MS. HIV-Related Health
Care Utilization Costs by Disease Status in the Era of HAART. 39th Interscience Conference
on Antimicrobial Agents and Chemotherapy, September 1999.
5. Johnson VA, Call SA, Westfall AO, Cloud GA, Acosta EP, Tolson JM, Larder BA, Saag MS. Predictive Value of Genotypic Resistance Testing as Interpreted by Experts and a Virtual
Phenotype. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy,
September 2000.
6. Chen RY, Westfall AO, Cloud GC, Chatham A, Acosta EP, Raper JL, Heudebert G, Saag MS. Long-term Survival After Initiation of Antiretroviral Therapy. 8th Conference on
Retroviruses and Opportunistic Infections, February 2001.

7. Smith T, Greene P, Smith-West D, Gore S, Westfall AO. High Risk Behavior in Women at
Risk for Cervical Cancer. University of Alabama at Birmingham Comprehensive Cancer
Center 2001 Annual Research Retreat, October 2001.
8. Chen RY, Mugavero MJ, Westfall AO, Cloud GA, Raper JL, Chatham A, Acosta EP, Taylor K, Saag MS. Durability of HAART Regimens Over Time. 41st Interscience Conference on
Antimicrobial Agents and Chemotherapy, Chicago, IL, December 16-19, 2001.
9. Chen RY, Mugavero MJ, Accortt NA, Westfall AO, Raper JL, Cloud GA, Stone BK, Carter J, Pisu M, Allison J, Saag MS. HIV Healthcare Costs Driven by CD4 Count and Medications,
Not Physician Fees. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy,
San Diego, CA, September 27 - 30, 2002.
10. Dorak MT, Tang J, Westfall AO, Zulu IS, Lobashevsky ES, Leakeas CL, Schaen MM, Kancheya NG, Allen SA, Kaslow RA. HLA class I effects on transmission of HIV-1c in heterosexual
Zambian couples: Risk of concordant HLA-B alleles. The XIV International AIDS
Conference, Barcelona, Spain, 2002 (July 7-12).
11. Mugavero MJ, Chen RY, Westfall AO, Cloud GA, Raper JL, Taylor KH, Carter J, Pisu M, Allison J, Saag MS. Increased Cost of Lipodystrophy (LD) in HIV Patients due to Higher
Clinic, Laboratory, and Medication Costs. 10th Conference on Retroviruses and Opportunistic
Infections, Boston, MA, 2003 (Feb 10-14).
12. Mikuls TR, Saag KG, Westfall AO, Howard G, Lim SS, Smith EA, Jonas B, Bridges SL Jr., Moreland LW. High Prevalence of Osteopenia/Osteoporosis among African Americans
with Early Rheumatoid Arthritis. ACR/ARHP Annual Scientific Meeting, Orlando, FL, 2003
(Oct 23-28).
13. Alarcón GS, Westfall AO, Gilkeson G, Jonas B, Conn D, Bridges SL Jr., Howard G, Moreland LW. Radiographic Abnormalities in African Americans with Early Rheumatoid Arthritis
(RA). ACR/ARHP Annual Scientific Meeting, Orlando, FL, 2003 (Oct 23-28).
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 14
14. Curtis JR, Allison J, Becker A, Casebeer L, George V, Kovac S, Spettell C, Westfall AO, Weissman N, Wilkie S, Saag KG. Screening and Treatment of Glucocorticoid Induced
Osteoporosis by 799 Physicians. International Society of Clinical Densitometry Annual
Scientific Meeting 2004, Miami, FL.
15. Fabres J, Wehrli G, Marques M, Phillips V, Dimmitt R, Westfall AO, Shelonka R. Analysis of
Risk Factors for Red Blood Cell Transfusions in VLBW Infants. 2004 Pediatric Academic
Societies' Meeting, San Francisco, CA, 2004 (May).
16. Curtis JR, Stewart E, Becker A, Allison JJ, Casebeer L, Elkins M, George V, Kiefe C, Panjamapiron A, Santhanakrishnan R, Spettell C, Weissman N, Westfall AO, Saag KG.
Recruiting Physicians to an Internet-based Quality Improvement Project: Effectiveness of
a Targeted, Multi-Phase, Incentive-Based Strategy. International Society of
Pharmacoepidemiology, Nashville, TN, August 2005.
17. Mikuls TR, Hughes LB, Westfall AO, Saag KG, Curtis J, Alarcon GS, Conn DL, Jonas BL, Callahan L, Smith EA, Gilkeson G, Howard G, Moreland LW, Bridges SL Jr. Association of
single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene with bone
mineral density (BMD) in African Americans with early rheumatoid arthritis. Arthritis
Rheum 2005; 52 (suppl): s118.
18. Kempf MC, Pisu M, Maherya A, Westfall AO, Saag MS. Gender Differences in
Discontinuation / Change in HIV Treatment. 6th Annual North American Cohorts Meeting,
Washington, DC, November 9-10 2005.
19. Morrison D, Hughes LB, Zhu Y, Westfall AO, Saag KG, Howard G, Alarcón GS, Moreland LW, Bridges SL Jr. Association Between Single Nucleotide Polymorphisms (SNPs) in the BTNL2
Gene and Rheumatoid Arthritis (RA) in African Americans. 22nd Annual DOM Trainee
Research Symposium, University of Alabama at Birmingham, March 1, 2006.
20. Dechanuwong P, Hughes LB, Morrison D, Zhu Y, Westfall AO, Howard G, Alarcón GS, Moreland LW, Bridges SL Jr. The Role of Autoantibodies and Single Nucleotide
Polymorphisms (SNPs) in the Osteoprotegerin Gene (OPG) in Radiographic Severity of
Early Rheumatoid Arthritis (RA) in African Americans: Results from the CLEAR
Registry. 22nd Annual DOM Trainee Research Symposium, University of Alabama at
Birmingham, March 1, 2006.
21. Van Wagoner N, Westfall AO, Chang PW, Krishnasami Z, Saag MS, Willig JH. Dosing Errors
in NRTI Prescriptions Based on Creatinine Clearance at the 1917 HIV Primary Care
Clinic and a Proposed Corrective Computerized Medical Record Intervention. 22nd Annual
DOM Trainee Research Symposium, University of Alabama at Birmingham, March 1, 2006.
22. Willig JH, Chen RY, Westfall AO, Cloud GA, Chang PW, Saag MS, Raper JL. Initial CD4
count in general versus pregnant population and its impact on policy. Should our testing
strategies change? 22nd Annual DOM Trainee Research Symposium, University of Alabama at
Birmingham, March 1, 2006.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 15


23. Kempf MC, Maherya A, Westfall AO, Cloud GA, Saag MS. Racial Differences in
Discontinuation of Efavirenz Treatment. 10th International Workshop on HIV Observational
Databases, Madrid, Spain, March 23-26 2006.
24. Kempf MC, Pisu M, Maherya A, Westfall AO, Saag, MS. Gender Differences in
Discontinuation / Change of HIV Treatment. 2nd North American Congress of Epidemiology.
Seattle, WA, June 21-24, 2006.
25. Shikany J, Barash J, Heimburger D, Henson S, Redden D, Westfall A, Allison D. Even the
experts can't agree: divergence in published recommended diets relative to diets consumed
by Americans, and possible implications for individualized diet selection. NAASO Annual
Scientific Meeting, Boston, Massachusetts, October 20-24, 2006.
26. Jackson D, Willig J, Westfall A, Saag M, Chang P, Allison J, Raper J, Mugavero M. Management of hyperlipidemia in an HIV cohort: Clinical inertia and failure to meet LDL
cholesterol goals. 11th International Workshop on HIV Observational Databases, 23-24 March
2007, Monte Carlo, Monaco, abstract 10C819.
27. Willig J, Westfall A, Saag M, Chang P, Raper J, Mugavero M. NRTI Prescription Errors in
an Outpatient HIV Clinic. 11th International Workshop on HIV Observational Databases, 23-
24 March 2007, Monte Carlo, Monaco, abstract 10C829.
28. Robison L, Westfall AO, Mugavero M, Colette-Kempf M, Cole S, Allison J, Willig J, Wilcox M, Saag M. Factors associated with short-term discontinuation of HAART regimens due to GI
toxicity. 45th Annual Meeting of the Infectious Diseases Society of America, 4-7 October 2007,
San Diego, CA, abstract 891.
29. Routman JS, Willig JH, Westfall AO, Saag MS, Mugavero MJ. Efficacy versus effectiveness
in HIV care: The HAART of the matter. 2007 Medical Student Research Day, University of
Alabama at Birmingham, October 9, 2007.
30. Routman J, Willig J, Westfall A, Abroms S, Varshney M, Adusumilli S, Allison J, Savage K, Saag M, Mugavero M. Similar Responses Observed in ARV-naïve Patients Treated through
Clinical Trials vs. Clinical Practice. 15th Conference on Retroviruses and Opportunistic
Infections, Boston, MA, February 3-6 2008.
31. Bedimo RJ, Westfall A, Mugavero M, Khanna N, Saag M. HCV is an Independent Risk
Factor for Acute Myocardial Infarction among HIV-Infected Veterans. 15th Conference on
Retroviruses and Opportunistic Infections, Boston, MA, February 3-6 2008.
32. Ulett KB, Willig JH, Westfall AO, Routman J, Abroms S, Allison JJ, Chatham A, Raper JL, Saag MS, Mugavero MJ. Factors associated with retention in care among an HIV cohort
following an initial outpatient visit. 3rd International Conference on HIV Treatment
Adherence, Jersey City, NJ, March 17-18 2008.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 16
33. Ulett KB, Willig JH, Westfall AO, Routman J, Abroms S, Allison JJ, Chatham A, Raper JL, Saag MS, Mugavero MJ. Appointment non-adherence is associated with delayed HAART
initiation in patients establishing HIV care. 3rd International Conference on HIV Treatment
Adherence, Jersey City, NJ, March 17-18 2008.
34. Reynolds NC, Roth DL, Lanier J, Westfall AO, Black BC, Tucker JA. Predictors of IVR Self-
Monitoring following Natural Problem Drinking Resolutions. 116th American Psychological
Association Convention, Boston, MA, August 14-17 2008.
35. Willig JH, Abroms S, Westfall AO, Routman J, Adusumilli S, Varshney M, Allison J, Raper JL, Saag MS, Mugavero MJ. Increased regimen longevity in the era of once daily fixed-dose
combination HAART. 12th International Workshop on HIV Observational Databases, 27-30
March 2008, Malaga, Spain, abstract 12C1083.
36. Westfall AO, Willig JH, Mugavero M, Varshney M, Adusumilli S, Allison J, Raper J, Saag MS. Information integrity: A pernicious menace to clinical cohort research. 12th International
Workshop on HIV Observational Databases, 27-30 March 2008, Malaga, Spain, abstract
12C1089.
37. Westfall AO, Adusumilli S, Raper JL, Willig JH, Allison J, Kumar M, Varshney M, Chang PW, Saag MS, Mugavero M. Symptom based versus routine screening strategy for anal
Papanicolau screening among MSM in an HIV infected cohort. 12th International Workshop
on HIV Observational Databases, 27-30 March 2008, Malaga, Spain, abstract 12C1086.
38. Kelley JM, Hughes LB, Faggard JD, Edberg JC, Danila MI, Crawford MH, Edberg Y, Padilla MA, Westfall AO, Alarcón GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD,
Kimberly RP, Moreland LW, Bridges SL Jr. An African Ancestry-Specific SNP Allele in
Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA4) Confers Protection Against
Rheumatoid Arthritis in African-Americans. ACR/ARHP Annual Scientific Meeting, San
Francisco, CA, October 24-29 2008.
39. McKinnell JA, Willig JH, Westfall AO, Allison JJ, Raper JL, Saag MS, Mugavero MJ. Contemporary Antiretroviral Therapy: Is it Time for the Generalist to Return? 48th
ICAAC/IDSA 46th Annual Meeting, Washington, DC, October 25-28, 2008.
40. King KE, Mwanahamuntu MH, Westfall AO, Hallock JL, Chisele S, Stringer JS, Parham G. The Association between HIV Status and Cervical Neoplasia as Detected in a Screen-and-
Treat Program in Lusaka, Zambia. 16th Conference on Retroviruses and Opportunistic
Infections, Montreal, Canada, February 8-11 2009.
41. Hallock JL, Mwanahamuntu MH, Westfall AO, King KE, Chisele S, Stringer JS, Parham G. Development of a Rule to Predict HIV+ Status in a Cervical Cancer Prevention Program.
16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, February 8-11
2009.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 17
42. Koethe JR, Westfall AO, Chi BH, Zulu I, Stringer JSA, Saag MS. A Randomized Trial of
Routine HIV-1 Viral Load Monitoring of Antiretroviral Therapy in Zambia:
Implementation, Baseline Cohort, and Early Findings. 47th Annual Meeting of IDSA,
Philadelphia, PA, October 29 – November 1 2009.
43. Cantrell R, Chi BH, Mwango A, Westfall AO, Mutale W, Limbada M, Mulenga LB, Vermund SH, Stringer JSA. An Empirical Approach to Defining Loss to Follow-up among
Patients Enrolled in Antiretroviral Treatment Programs. 17th Conference on Retroviruses
and Opportunistic Infections, San Francisco, CA, February 16-19 2010.
44. King KE, Mwanahamuntu MH, Westfall AO, Hallock J, Chisele S, Chi B, Stringer JSA, Parham G. The Association Between HIV Status and Cervical Neoplasia as Detected in a See-and-
Treat Program in Lusaka, Zambia. Scientific Session of the Fogarty International Clinical
Research Scholars Program Interview and Selection Meeting, Bethesda, MD, February 28 –
March 2, 2010.
45. Schöni-Affolter F, Keiser O, Chi B, Ledergerber B, Westfall A, Mulenga L, Egger M, Stringer J. Loss to follow-up: Comparative study of HIV infected patients in Zambia and Switzerland.
14th International Workshop on HIV Observational Databases, 25–27 March 2010, Sitges,
Spain.
46. Chi BH, Westfall AO, Fox M, Mulenga LB, Boulle A, Egger M, Stringer JSA. Empirically
defining lost to follow-up for ART programs in southern Africa. 14th International Workshop
on HIV Observational Databases, 25–27 March 2010, Sitges, Spain.
47. Chi BH, Westfall AO, Fox M, Mulenga LB, Boulle A, Egger M, Stringer JSA. Empirically
defining lost to follow-up for antiretroviral therapy programs in southern Africa. The
XVIII International AIDS Conference, 18-23 July 2010, Vienna, Austria.
48. King KE, Mwanahamuntu MH, Westfall AO, Sahasrabuddhe VV, Mudenda V, Hallock J, Chi BH, Vermund SH, Stringer JSA, Parham G. The Association Between HIV Status, HAART
and Cervical Neoplasia as Detected in a See-and-Treat Program in Lusaka, Zambia. 2010
Global Health Clinical Research Alumni Symposium, September 24-26 2010, Washington DC.
49. Abroms A, Westfall A, Harris J, Turnbull E, Kancheya N, Reid S, Henostroza G. Tuberculosis
screening practices in HIV-infected adult patients enrolled at Chawama, Kanyama, and
Matero Reference ART clinics in Lusaka, Zambia. 2010 Medical Student Research Day,
University of Alabama at Birmingham, October 26, 2010.
50. Trollip S, Abroms S, Westfall A, Harris J, Turnbull E, Kancheya N, Mwaba P, Reid S, Henostroza G. Tuberculosis screening practices among patients enrolled into HIV Care in
Lusaka, Zambia. 41st Union World Conference on Lung Health, 11-15 November 2010, Berlin,
Germany.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 18
51. Keiser O, Chi B, Gsponer T, Boulle A, Orrell C, Phiri S, Westfall A, Maskew M, Prozesky H, Egger M. Immunological Response and Mortality in ART Programmes with and without
Routine Viral Load Monitoring in Southern Africa. 18th Conference on Retroviruses and
Opportunistic Infections, Boston, MA, February 27-March 2 2011. Abstract # Z-112.
52. Schöni-Affolter F, Keiser O, Chi B, Ledergerber B, Westfall A, Mulenga L, Egger M, Stringer J. Competing Risks: Loss to Follow-up and Mortality in HIV Cohort Studies in Zambia and
Switzerland. 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA,
February 27-March 2 2011. Abstract # Z-136.


PUBLISHED ABSTRACTS (incomplete):

1. Kohler C, Greene P, West D, Siegfried N, Gilliland J, Westfall AO. Targeting High Risk
Individuals for Prevention Trials. Annals of Behavioral Medicine, 23, S082 (2001).

2. Greene P, West D, Partridge E, Davies S, Donovan K, Westfall AO. Tobacco Risk Reduction
and Cervical Cancer Prevention. Annals of Behavioral Medicine, 23, S082 (2001).
3. Kohler C, Greene P, Smith-West D, Partridge E, Davies S, Gore S, Siegfried N, Westfall AO. Brief Risk Communication in a Medical Setting Influences Tobacco Use and Readiness to
Quit. Annals of Behavioral Medicine, 24, S167 (2002).
4. Gore S, Greene P, Smith-West D, Partridge E, Davies S, Kohler C, Siegfried N, Westfall AO. Changing Smoking Habits in Women at Risk for Cervical Cancer. Annals of Behavioral
Medicine, 24, S166 (2002).
5. Alarcón GS, Westfall AO, Gilkerson G, Callahan L, Conn D, Bridges SL Jr., Howard G, Moreland LW. Joint damage occurs early in African-Americans with rheumatoid arthritis
(RA). Arthritis Rheum 48:S109 (2003).
6. Callahan LF, Jonas B, Westfall AO, Smith EA, Conn D, Oliver E, Howard G, Bridges SL Jr., Moreland LW. Health-related quality of life in African-Americans with early rheumatoid
arthritis. Arthritis Rheum 48:S249 (2003).
7. Callahan LF, Jonas B, Westfall AO, Gilkerson G, Conn D, Gala P, Howard G, Bridges SL Jr., Moreland LW. Complementary and alternative medicine use in African-Americans with
early rheumatoid arthritis (RA). Arthritis Rheum 48:S250 (2003).
8. Mikuls TR, Saag KG, Westfall AO, Howard G, Lim SS, Smith EA, Jonas BL, Bridges SL Jr., Moreland LW. High prevalence of osteopenia/osteoporosis among African-Americans with
early rheumatoid arthritis. Arthritis Rheum 48:S299 (2003).
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 19
9. Curtis, JR, Allison J, Becker A, Bijlsma JWJ, Casebeer, L, George V, Kovac S, Spettell C, Westfall AO, Weissman N, Wilkie S, Saag KG. Adverse Events associated with Chronic
Glucocorticoid Use among 2446 Adults. Arthritis and Rheumatism; 50 (S9): S301 (2004).
10. Curtis, JR, Allison J, Becker A, Bijlsma JWJ, Casebeer, L, George V, Kovac S, Spettell C, Westfall AO, Weissman N, Wilkie S, Saag KG. Screening and Treatment of Glucocorticoid
Induced Osteoporosis among 6517 Adults. Arthritis and Rheumatism; 50(S9): S314 (2004).
11. Curtis, JR, Allison J, Becker A, Bijlsma JWJ, Casebeer, L, George V, Kovac S, Spettell C, Westfall AO, Weissman N, Wilkie S, Saag KG. Screening and Treatment of Glucocorticoid
Induced Osteoporosis among 6517 Adults. Journal of Bone and Mineral Research; 19(S1):
S30 (2004).
12. Curtis JR, Westfall AO, Allison JJ, Freeman A, Kiefe CI, Saag KG. Persistence and adherence
to alendronate and risedronate among chronic glucocorticoid users. Arthritis Rheum 52(9
Suppl):S734-S735 (2005).
13. Curtis JR, Becker A, Allison JJ, Casebeer L, Elkins M, George V, Kiefe C, Panjamapiron A, Santhanakrishnan R, Spettell C, Weissman N, Westfall AO, Saag KG. Recruiting Physicians to
an Internet-based Quality Improvement Project: Effectiveness of a Targeted, Multi-Phase,
Incentive-Based Strategy. Pharmacoepudemiol Drug Saf 14:S95-S96 (2005)
14. Curtis JR, Westfall AO, Allison JJ, Freeman A, Kiefe CI, Saag KG. Persistence and
Adherence to Alendronate And Risedronate Among Chronic Glucocorticoid Users. J Bone
Min Res 20 (Suppl 1):S279 (2005).
15. Curtis JR, Allison JJ, Westfall AO, Sampsel S, Kovac SH, Saag KG. Agreement and
validation of self-report and pharmacy data for use of anti-osteoporotic medications.
Pharmacoepidemol Drug Saf 14:S194-S195 (2005).
16. Curtis JR, Westfall AO, Allison JJ, Freeman A, Saag KG. A comparison of self-report and
pharmacy data for current use of anti-osteoporotic medications. J Bone Min Res 20 (Suppl
1):S403 (2005).
17. Curtis JR, Westfall A, Cheng H, Delzell E, Lyles K, Saag KG. Bisphosphonates Adherence
and Fracture Risk: Time-Dependent Relationships form 103,038 Bisphosphonate Users in
the U.S. Journal of Bone and Mineral Research 2007; 22(1):S130.
18. Curtis JR, Westfall A, Cheng H, Delzell E, Lyles K, Saag KG. Longitudinal Patterns of
Adherence with Bisphosphonates. Journal of Bone and Mineral Research 2007; 22(1):S214.

19. Curtis JR, Westfall A, Cheng H, Delzell E, Saag KG. How Quickly Do Oral Bisphosphonates
Work, and Are There Differences Between Them? Journal of Bone and Mineral Research
2007; 22(1):S326.
CURRICULUM VITAE
Andrew O. Westfall M.S.
Page 20

TECHNICAL REPORTS (incomplete):

1. Contributor to the Proposed Reports and Statistical Models to Address: The Reorganized Operational Questions for National Study, Washington, D.C. 3/26/95. 2. Contributor to the Information Systems Report for the Evaluation of the Head Start/Public School Early Childhood Transition Demonstration Project, Washington, D.C. 6/20/95. 3. Contributor to the CREST Data and Safety Monitoring Report, Washington, D.C. 5/31/02. 4. Contributor to the SPS3 Data and Safety Monitoring Report, San Diego, CA. 2/4/04. 5. Koethe J, Luhanga D, Westfall AO. Effectiveness of HIV Viral Load Monitoring on Patient Outcomes in Resource-Poor Settings First Data and Safety Monitoring Report. 3/10/09. 6. Westfall AO. Effectiveness of HIV Viral Load Monitoring on Patient Outcomes in Resource- Poor Settings Second Data and Safety Monitoring Report. 3/10/10.

Source: http://sparkmancenter.net/files/Faculty/Westfall-CV.pdf